Pull to refresh
Logo
What Changed
Following Why Sign Up
CVS settles federal opioid prescribing case for $315M

CVS settles federal opioid prescribing case for $315M

Rule Changes

Justice Department ends 12-year dispensing case; CVS adopts new oversight measures without admitting wrongdoing

October 16th, 2026: Foulkes addresses opioid settlement in governor race

Overview

Updated Oct 27

CVS Pharmacy agreed to pay $315 million to settle federal allegations that it illegally filled opioid and other controlled-substance prescriptions from October 2013 through December 2025. It then billed Medicare and other federal programs for many of those invalid prescriptions. CVS admitted no wrongdoing, and the allegations remain unproven.

The Justice Department sued in December 2024, citing "pill mill" prescribers and dangerous "trinity" combinations of an opioid, a benzodiazepine and a muscle relaxant. A separate memorandum with the Drug Enforcement Administration (DEA) runs through August 15, 2032. It covers CVS retail stores, not its Caremark specialty or mail-order pharmacies. CVS must set up a hotline, monitor dispensing patterns and screen suspect prescribers. Commentary published October 22 notes the memorandum does not require CVS to track what happens to patients after prescribers are blocked.

Why it matters

The deal forces one of America's largest pharmacy chains to install opioid monitoring systems, a new compliance standard for every pharmacy filling controlled substances.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$315M
Federal settlement amount
CVS pays to resolve DOJ opioid prescribing and False Claims Act allegations.
$5B
2022 state and tribal settlement
CVS's earlier, larger opioid settlement with states, localities, and tribes.
12 years
Years of alleged violations
DOJ alleged unlawful dispensing from October 2013 through December 2025.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

Log in Sign Up

People Involved

Brett A. Shumate
Brett A. Shumate
Assistant Attorney General, Justice Department Civil Division
Announced the CVS settlement on October 13, 2026
HE
Hillary Estright
Whistleblower, former CVS employee
Filed qui tam lawsuit in 2022; award share not yet determined
 Helena Foulkes
Helena Foulkes
Former CVS Pharmacy president; Rhode Island gubernatorial candidate
Responded to settlement questions on October 16, 2026

Organizations Involved

PI
CVS Pharmacy Inc.
Retail pharmacy chain
Pay $315M settlement; admitted no wrongdoing

One of America's largest pharmacy chains, operating thousands of retail locations nationwide.
United States Department of Justice
United States Department of Justice
Federal agency
Filed and resolved the lawsuit

The federal executive department responsible for enforcing U.S. law, including the Controlled Substances Act and False Claims Act.
Drug Enforcement Administration (DEA)
Drug Enforcement Administration (DEA)
Federal law enforcement agency
Signed memorandum of agreement with CVS for future compliance

The federal agency that enforces the Controlled Substances Act and regulates the dispensing of controlled substances.

Timeline

October 2013 October 2026

6 events Latest: October 16th, 2026 · 4 weeks ago
Tap a bar to jump to that date

  1. Foulkes addresses opioid settlement in governor race

    Latest Political

    Former CVS Pharmacy president Helena Foulkes, now a Democratic candidate for Rhode Island governor, said she was not a 'bad actor' and that CVS cut off 600 pill mill doctors during her tenure.

  2. CVS confirms settlement and compliance terms

    Settlement

    CVS confirms the $315 million settlement including DEA oversight agreement.

  3. DOJ announces $315M settlement

    Settlement

    CVS agrees to pay $315 million; admits no wrongdoing.

  4. DOJ files opioid lawsuit against CVS

    Legal

    Justice Department files civil complaint in U.S. District Court for Rhode Island.

  5. CVS pays $5B to states and tribes

    Settlement

    CVS agrees to nearly $5 billion settlement with state, local, and tribal governments.

  6. Alleged unlawful dispensing begins

    Investigation

    DOJ later alleges CVS began filling unlawful opioid prescriptions on this date.

Scenarios

1

CVS completes compliance overhaul without further federal action

Likely Resolves by Oct 13, 2027

Discussed by: Healthcare Dive, TIKR.com analysts

CVS implements the DEA memorandum of agreement: hotline, dispensing monitoring, prescriber screening. Financial-strain claim removed from this scenario pending verification of the TIKR analysis. If compliance holds and no new violations surface, the federal case closes.

2

Whistleblower award set in CVS settlement

Likely Resolves by Oct 13, 2028

Discussed by: Bloomberg Law, court observers

Hillary Estright, the former CVS employee who filed the 2022 qui tam lawsuit, is entitled to a share of the $315 million recovery under the False Claims Act. The court determines her award, typically 15-25% of the recovery in intervened cases.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

August 2026

Walmart DOJ Opioid Settlement (August 2026)

Walmart agreed to pay $50 million to resolve a similar DOJ lawsuit over opioid dispensing, far less than CVS's $315 million settlement. The difference in scale reflects the specific allegations and company size.

Then

Walmart avoided prolonged litigation and further reputational damage.

Now

The settlement reinforced the DOJ's pattern of pursuing pharmacy chains for opioid dispensing.

Why this matters now

Shows the range of federal opioid settlements, with CVS at the higher end.

2022

CVS State and Tribal Settlement (2022)

CVS agreed to pay nearly $5 billion to settle thousands of claims by states, localities, and Native American tribes over its role in the opioid epidemic. That settlement covered dispensing and distribution practices.

Then

CVS resolved a wave of civil claims without admitting wrongdoing.

Now

The 2022 settlement didn't preclude federal action, demonstrated by the 2026 DOJ resolution.

Why this matters now

The federal settlement adds to CVS's total opioid liabilities, which exceed $5 billion across all cases.

September 2019

Purdue Pharma Bankruptcy (September 2019)

OxyContin maker Purdue Pharma filed for Chapter 11 bankruptcy amid thousands of lawsuits from states, cities, and individuals over its role in the opioid crisis. The company faced billions in potential liability.

Then

Bankruptcy paused litigation while Purdue negotiated a settlement plan.

Now

The case established that opioid manufacturers and distributors face massive liability, setting a precedent for pharmacy chains like CVS.

Why this matters now

Illustrates the accountability wave that eventually reached pharmacies directly involved in dispensing.

Sources

(10)
+4
U.S. Department of Justice, Office of Public Affairs Healthcare Dive Associated Press U.S. Department of Health and Human Services, Office of Inspector General Bloomberg Law Honolulu Star-Advertiser TIKR.com BioPharma Dive WJAR NBC 10 This Is The Antidote